Annual CFO
-$21.95 M
+$609.00 K+2.70%
31 December 2023
Summary:
NKGen Biotech Warrants annual cash flow from operations is currently -$21.95 million, with the most recent change of +$609.00 thousand (+2.70%) on 31 December 2023. During the last 3 years, it has fallen by -$2.40 million (-12.28%). NKGNW annual CFO is now -12.28% below its all-time high of -$19.55 million, reached on 31 December 2021.NKGNW Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$6.00 M
-$1.97 M-48.71%
30 June 2024
Summary:
NKGen Biotech Warrants quarterly cash flow from operations is currently -$6.00 million, with the most recent change of -$1.97 million (-48.71%) on 30 June 2024. Over the past year, it has increased by +$940.00 thousand (+13.55%). NKGNW quarterly CFO is now -48.71% below its all-time high of -$4.03 million, reached on 31 March 2024.NKGNW Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$21.54 M
-$469.00 K-2.23%
30 June 2024
Summary:
NKGen Biotech Warrants TTM cash flow from operations is currently -$21.54 million, with the most recent change of -$469.00 thousand (-2.23%) on 30 June 2024. Over the past year, it has dropped by -$4.50 million (-26.44%). NKGNW TTM CFO is now -294.02% below its all-time high of -$5.47 million, reached on 31 December 2022.NKGNW TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKGNW Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +13.6% | -26.4% |
| 3 y3 years | -12.3% | - | - |
| 5 y5 years | - | - | - |
NKGNW Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -12.3% | +2.7% | -48.7% | +13.6% | -294.0% | at low |
| 5 y | 5 years | -12.3% | +2.7% | -48.7% | +13.6% | -294.0% | at low |
| alltime | all time | -12.3% | +2.7% | -48.7% | +13.6% | -294.0% | at low |
NKGen Biotech Warrants Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$6.00 M(+48.7%) | -$21.54 M(+2.2%) |
| Mar 2024 | - | -$4.03 M(-41.9%) | -$21.07 M(+23.7%) |
| Dec 2023 | -$21.95 M | -$6.94 M(+52.0%) | -$17.03 M(+9.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$4.57 M(-17.5%) | -$15.56 M(+41.5%) |
| June 2023 | - | -$5.53 M(+1.2%) | -$11.00 M(+101.2%) |
| Dec 2022 | -$22.56 M(+15.4%) | -$5.47 M | -$5.47 M |
| Dec 2021 | -$19.55 M | - | - |
FAQ
- What is NKGen Biotech Warrants annual cash flow from operations?
- What is the all time high annual CFO for NKGen Biotech Warrants?
- What is NKGen Biotech Warrants quarterly cash flow from operations?
- What is the all time high quarterly CFO for NKGen Biotech Warrants?
- What is NKGen Biotech Warrants quarterly CFO year-on-year change?
- What is NKGen Biotech Warrants TTM cash flow from operations?
- What is the all time high TTM CFO for NKGen Biotech Warrants?
- What is NKGen Biotech Warrants TTM CFO year-on-year change?
What is NKGen Biotech Warrants annual cash flow from operations?
The current annual CFO of NKGNW is -$21.95 M
What is the all time high annual CFO for NKGen Biotech Warrants?
NKGen Biotech Warrants all-time high annual cash flow from operations is -$19.55 M
What is NKGen Biotech Warrants quarterly cash flow from operations?
The current quarterly CFO of NKGNW is -$6.00 M
What is the all time high quarterly CFO for NKGen Biotech Warrants?
NKGen Biotech Warrants all-time high quarterly cash flow from operations is -$4.03 M
What is NKGen Biotech Warrants quarterly CFO year-on-year change?
Over the past year, NKGNW quarterly cash flow from operations has changed by +$940.00 K (+13.55%)
What is NKGen Biotech Warrants TTM cash flow from operations?
The current TTM CFO of NKGNW is -$21.54 M
What is the all time high TTM CFO for NKGen Biotech Warrants?
NKGen Biotech Warrants all-time high TTM cash flow from operations is -$5.47 M
What is NKGen Biotech Warrants TTM CFO year-on-year change?
Over the past year, NKGNW TTM cash flow from operations has changed by -$4.50 M (-26.44%)